Biden’s Drug Pricing Push, ChatGPT for Business, & Meta’s Disinformation Discovery 8/29/23

The Biden administration has unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. CNBC’s Bertha Coombs and Centers for Medicare and Medicaid Services Administrator, Chiquita Brooks-Lasure, discuss the announcement, how the list of drugs were chosen, and more. Amazon CEO Andy Jassy is reportedly ready to let go of remote employees who’d rather stay remote, and OpenAI is launching its chatbot business tier, called ChatGPT Enterprise. Plus, CNBC’s Eamon Javers reports, Meta says it has disrupted a disinformation campaign linked to Chinese law enforcement, what the platform has called the “largest known cross-platform covert influence operation in the world.” Bertha Coombs 15:50 Chiquita Brooks-LaSure 20:33 Eamon Javers 28:17 In this episode: Becky Quick, @BeckyQuick Joe Kernen, @JoeSquawk Eamon Javers, @EamonJavers Chiquita Brooks-LaSure, @BrooksLaSureCMS Bertha Coombs, @berthacoombs Katie Kramer, @Kramer_Katie